In a move to enhance Hong Kong’s status as a global business and financial hub, and to attract foreign companies to take advantage of Hong Kong’s taxation system and professional services–thereby encouraging investment and...more
6/16/2025
/ Business Entities ,
Corporate Taxes ,
Eligibility ,
Filing Requirements ,
Financial Services Industry ,
Foreign Corporations ,
Foreign Investment ,
Hong Kong ,
International Tax Issues ,
Investment ,
New Legislation ,
Non-Domiciled Investors
On May 21, 2025, Hong Kong’s Legislative Council passed the Stablecoins Bill, establishing a regulatory framework for stablecoins–cryptocurrencies whose value is tied to an external asset or commodity. This marks an important...more
5/27/2025
/ Cryptocurrency ,
Digital Assets ,
Financial Institutions ,
Financial Regulatory Reform ,
Hong Kong ,
Hong Kong Monetary Authority (HKMA) ,
Investment ,
Investors ,
Licensing Rules ,
New Legislation ,
Regulatory Oversight ,
Regulatory Requirements ,
Retail Investors ,
Stablecoins ,
Virtual Currency
On February 13th 2025, Supreme People’s Court of The People’s Republic of China (“PRC”) issued the Reply on Validity of Agreements by Hong Kong and Macao-Invested Enterprises Registered in Mainland Cities of the...more
2025年1月20日，特朗普政府发布了多项与移民相关的行政命令，重点涉及边境安全、人道主义计划的撤回、对签证申请人的审查升级，以及试图终止出生公民权。此外，拜登总统发布的多项行政命令被废除。以下我们将讨论这些命令对拥有外籍员工的雇主产生的一些主要影响。...more
1/28/2025
/ Border Security ,
Employment Policies ,
Executive Orders ,
Foreign Nationals ,
Foreign Workers ,
Form I-9 ,
Highly-Skilled Workers Visa ,
Immigration and Customs Enforcement (ICE) ,
Immigration Procedures ,
Immigration Reform ,
STEM ,
Trump Administration ,
USCIS ,
Visas
Seyfarth Synopsis: To bring Hong Kong’s Foreign-Sourced Income Exemption (FSIE) regime in line with the European Union’s updated guidance on FSIE regimes promulgated in December 2022, the Inland Revenue (Amendment) (Taxation...more
To bring Hong Kong’s Foreign-Sourced Income Exemption (FSIE) regime in line with the European Union’s updated guidance on FSIE regimes promulgated in December 2022, the Inland Revenue (Amendment) (Taxation on Foreign-sourced...more
中美贸易：敏感技术的对外投资管制制度
Executive Order on Outbound Investment 有关对外投资的行政令 -
A new executive order signed by President Biden in August 2023 restricts outbound investment to China in several critical cutting-edge technologies...more
On 14 April 2023, the Stock Exchange of Hong Kong Limited (“HKSE”) published a consultation paper seeking market feedback on proposals to enhance climate-related disclosures under the current ESG framework for listed...more
Background -
Investors and asset managers continue to emphasize environmental, social, and governance (“ESG”) factors as drivers of financial value in their investment products....more
Introduction -
On June 10, 2021, China officially passed China’s first Data Security Law, which will take effect on September 1, 2021. Following the introduction of the Data Security Law, together with the Cybersecurity Law,...more
As the world progresses with COVID vaccinations, the scenario where you have to show a COVID passport before crossing a border, taking a public mode of transportation, or entering a public space like a cinema no longer seems...more
The COVID-19 outbreak inevitability has spurred unprecedented progress on a paradigm shift to telemedicine. According to a recent study by the Boston Consulting Group, China is already the world’s third largest Med Tech...more
4/10/2020
/ Centers for Medicare & Medicaid Services (CMS) ,
China ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Emergency Response ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Investors ,
Med Tech ,
Medicare ,
Physicians ,
Public Health ,
Relief Measures ,
Telehealth ,
Telemedicine
China is cautiously recovering from the peak of the COVID-19 outbreak and is moving into a new period of investor-friendly policies aimed at restarting China’s economic engine....more
4/9/2020
/ Artificial Intelligence ,
Best Practices ,
Biologics ,
China ,
Coronavirus/COVID-19 ,
Health and Safety ,
Infectious Diseases ,
Investors ,
Life Sciences ,
Med Tech ,
Medical Devices ,
Pharmaceutical Industry ,
Policies and Procedures ,
Public Health ,
Risk Management ,
Robotics ,
Supply Chain